Germany· DE-A57-0ba72eaae7f8ecff
Fosphenytoin Desitin
A fosphenytoin product containing fosphenytoin sodium, registered in Germany by Desitin Arzneimittel Gmbh. The same ATC class is registered in 11 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Fosphenytoin is registered in 11 of 19 countries.
Countries holding a registration under ATC N03AB05 (fosphenytoin), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 4 of them publish a price we can compare per daily dose
Fosphenytoin · ATC N03AB05
11 / 19 countries
- Canada
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Japan
- Norwayprice
- Sweden
- United Kingdom
- United Statesprice
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Fosphenytoin Sodium
- Manufacturer
- Desitin Arzneimittel Gmbh
- Country
- Germany (DE)
- ATC code
- N03AB05
- ATC class
- Fosphenytoin
- Defined daily dose
- 0.45 g, P
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- August 5, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
430 interactions on record for fosphenytoin.
Graded by severity as the source publishes them — 128 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Fosphenytoin · interactions on record
430 records
- 128 severe
- 275 moderate
- 10 minor
- 17 info
Most severe, free to view
- CimetidineA02BA01severe
- RolapitantA04AD14severe
- NaloxegolA06AH03severe
- NaldemedineA06AH05severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Fosphenytoin in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCEREBYXPfizer Laboratories Div Pfizer Inc
- SwedenFosphenytoin Eugia 75 mg/ml (50 mg FE/ml) Koncentrat till injektions-/infusionsvätska, lösningEugia Pharma (Malta) Limited
- FinlandPro-EpanutinPfizer Oy
- FrancePRODILANTIN 75 mg/mL, solution à diluer pour perfusion/solution injectablePFIZER HOLDING FRANCE
- United KingdomPro-Epanutin 750mg/10ml concentrate for solution for injection vialsPfizer Ltd
- CanadaCEREBYXSEARCHLIGHT PHARMA INC
- IcelandPro-EpanutinPfizer ApS
- NorwayPro-EpanutinPfizer AS
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Denmark · Pro-Epanutin
- Finland · Pro-Epanutin
- France · Fosphenytoine Arrow, Prodilantin
- United Kingdom (Northern Ireland) · Pro-Epanutin
- Ireland · Pro-Epanutin
- Iceland · Pro-Epanutin
- Norway · Pro-Epanutin
- Sweden · Fosphenytoin Eugia, Fosphenytoin Frost
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/30ff08bb-8f34-4df9-a879-50bf32828499 GET /v1/drugs/30ff08bb-8f34-4df9-a879-50bf32828499?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intramuscular Use, Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Fosphenytoin Sodium",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about fosphenytoin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.